Being that the drug is backed by both safety and effectiveness data and the only concern being the 3rd party manufacturing, I see a small obstacle that can be easily addressed. With the concerns of the FDA being addressed by the company here shortly, I see a lot of upside with this stock. I am not promoting, but wanting to tap into others opinions. With a partnering with Redhill and Par already, I don't see how the manufacturing site will not be addressed by all 3 companies who will reap benefits by its approval. I choose to avoid these stocks, but again wanted others opinions good an bad.